CCL21 Cancer Immunotherapy
Cancer, a major health problem, affects 12 million people worldwide every year. With surgery and chemo-radiation the long term survival rate for the majority of cancer patients is dismal. Thus novel treatments are urgently needed. Immunotherapy, the harnessing of the immune system to destroy cancer...
Main Authors: | Lin, Yuan, Sharma, Sherven, John, Maie St. |
---|---|
Format: | Online |
Language: | English |
Published: |
MDPI
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074818/ |
Similar Items
-
Novel CCL21-Vault Nanocapsule Intratumoral Delivery Inhibits Lung Cancer Growth
by: Kar, Upendra K., et al.
Published: (2011) -
CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions
by: Akhavanpoor, Mohammadreza, et al.
Published: (2014) -
Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy
by: Sand, Laurens G. L., et al.
Published: (2016) -
SLC/CCL21-mediated anti-tumor responses require IFNγ, MIG/CXCL9 and IP-10/CXCL10
by: Sharma, Sherven, et al.
Published: (2003) -
Higher Expression of CCL2, CCL4, CCL5, CCL21, and CXCL8 Chemokines in the Skin Associated with Parasite Density in Canine Visceral Leishmaniasis
by: Menezes-Souza, Daniel, et al.
Published: (2012)